GO:0032376 positive regulation of cholesterol transport: Cellular Lipid Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032376 describes any process that activates or increases the directed movement of cholesterol into, out of, or within a cell, by means of transporters or pores.
• Key molecular players include ABCA1, TREM2, DOCK7, PCK1, INSIG1/2, TM4SF5, and sphingosine-1-phosphate signaling components.
• Positive regulation of cholesterol transport is critical for intestinal immune responses, macrophage foam cell formation, and tumor metastasis.
• Dysregulation of this process contributes to atherosclerosis, colorectal cancer, and metabolic disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of cholesterol transport regulators.
• EDITGENE provides end-to-end CRISPR services including library screening and bioinformatics for cholesterol transport research.
Description
Cholesterol is an essential lipid that must be precisely distributed within and between cells to maintain membrane integrity, support signaling, and enable immune responses. The Gene Ontology term GO:0032376, positive regulation of cholesterol transport, captures the processes that activate or increase the directed movement of cholesterol into, out of, or within a cell, by means of transporters or pores. This term is distinct from cholesterol transport itself because it specifically refers to the upregulation or activation of that movement, a critical layer of control in lipid homeostasis. Researchers study this process because its dysregulation underlies major human diseases including atherosclerosis, cancer, and metabolic syndrome. Recent work has shown that T cell cholesterol transport links intestinal immune responses to dietary lipid absorption, highlighting the systemic importance of this regulation. Similarly, the gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 to drive lipogenesis, connecting cholesterol regulation to glucose metabolism. Understanding the molecular mechanisms that positively regulate cholesterol transport is therefore essential for developing targeted therapies and for interpreting genome-wide association studies that implicate lipid transporters in disease.
positive regulation of cholesterol transport At A Glance
| GO ID | GO:0032376 |
|---|---|
| GO term | positive regulation of cholesterol transport |
| Ontology | biological_process |
| Synonym | activation of cholesterol transport, stimulation of cholesterol transport, up regulation of cholesterol transport, up-regulation of cholesterol transport, upregulation of cholesterol transport |
| Major function | Activates or increases the directed movement of cholesterol into, out of, or within a cell, or between cells, via transporters or pores |
| Related processes | Cholesterol efflux, cholesterol uptake, reverse cholesterol transport, foam cell formation, lipogenesis |
| Key transporters | ABCA1, TREM2, DOCK7, TM4SF5, INSIG1/2 |
| Disease relevance | Atherosclerosis, colorectal cancer, metabolic disorders, immune dysregulation |
What Is GO:0032376?
GO:0032376, positive regulation of cholesterol transport, is defined as any process that activates or increases the frequency, rate, or extent of the directed movement of cholesterol into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. In simpler terms, it is the set of molecular events that boost how cholesterol is moved around, whether that means exporting it from a cell, importing it, or redistributing it internally. This term sits under the broader biological process of cholesterol transport and is a positive regulatory node, meaning it describes gain-of-function or stimulatory mechanisms rather than the transport event itself.
Why Is positive regulation of cholesterol transport Important in Cell Biology?
Positive regulation of cholesterol transport is important because cholesterol movement is a central node in cellular lipid homeostasis, immune function, and disease progression. When this regulation goes awry, cholesterol can accumulate in macrophages to form foam cells, a hallmark of atherosclerosis. In cancer, tumor-associated macrophages can deliver DOCK7-enriched extracellular vesicles that drive metastasis via the RAC1/ABCA1 axis, directly linking positive regulation of cholesterol transport to tumor progression. Moreover, T cell cholesterol transport connects intestinal immune responses to dietary lipid absorption, showing that this process integrates systemic metabolism with immunity. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 to promote lipogenesis, further demonstrating crosstalk between glucose metabolism and cholesterol regulation. Because of these broad implications, researchers need robust models to dissect the causal roles of specific genes in this process.
• Controls cholesterol efflux from macrophages, preventing foam cell formation and atherosclerosis.
• Regulates intestinal immune responses and dietary lipid absorption through T cell cholesterol transport.
• Promotes tumor metastasis via DOCK7-enriched extracellular vesicles and the RAC1/ABCA1 axis.
• Connects glucose metabolism to lipogenesis through PCK1-mediated phosphorylation of INSIG1/2.
• Modulates mitochondrial reprogramming and cancer cell metabolism via TM4SF5-enriched contact sites.
• Influences sphingosine-1-phosphate signaling, which regulates ABCA1-mediated cholesterol efflux.
• Impacts neurosteroid binding and ion channel function, as cholesterol regulates TRP channels and NMDA receptors.
• Provides therapeutic targets for metabolic syndrome, cardiovascular disease, and cancer.
• Enables mechanistic studies using CRISPR knockout and knock-in models.
• Supports biomarker discovery and drug screening through high-throughput CRISPR library screening.
What Happens During positive regulation of cholesterol transport?
Initiation by extracellular or intracellular signals
In simple terms: The process starts when a signal tells the cell to move more cholesterol.
Positive regulation of cholesterol transport is initiated by diverse signals, including dietary lipids, inflammatory cytokines, and metabolic cues. For example, T cell cholesterol transport links intestinal immune responses to dietary lipid absorption, meaning that dietary lipids can trigger increased cholesterol movement in immune cells. Similarly, glucose availability can drive mitochondrial reprogramming by cholesterol export at TM4SF5-enriched mitochondria-lysosome contact sites, showing that metabolic status initiates this regulation. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 to promote lipogenesis, providing a direct link between glucose signaling and cholesterol regulation.
Activation of cholesterol transporters and pores
In simple terms: Specific proteins act as doors or pumps to move cholesterol faster.
Once initiated, positive regulation of cholesterol transport involves activation of transporters such as ABCA1, which mediates cholesterol efflux to apolipoproteins. Sphingosine-1-phosphate signaling regulates ABCA1-mediated cholesterol efflux in macrophages, demonstrating a specific activation mechanism. TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis, acting as a receptor that increases cholesterol internalization. DOCK7-enriched extracellular vesicles from tumor-associated macrophages drive tumor metastasis via the RAC1/ABCA1 axis, highlighting how vesicular transport can positively regulate cholesterol movement. TM4SF5 at mitochondria-lysosome contact sites facilitates cholesterol export, linking organelle contact sites to transport regulation.
Cellular and systemic consequences
In simple terms: Moving more cholesterol changes how cells behave and can affect the whole body.
The consequences of positive regulation of cholesterol transport are cell-type specific. In macrophages, increased cholesterol uptake via TREM2 leads to foam cell formation, a key step in atherosclerosis. In T cells, cholesterol transport links intestinal immune responses to dietary lipid absorption, influencing systemic lipid handling. In cancer, DOCK7-enriched extracellular vesicles drive metastasis through the RAC1/ABCA1 axis, showing that positive regulation of cholesterol transport can promote tumor progression. Additionally, cholesterol regulation affects ion channels such as TRP channels and NMDA receptors, with neurosteroid binding modulating NMDA receptor conductance.
Feedback and crosstalk with other metabolic pathways
In simple terms: The process is tuned by feedback loops and talks to other metabolic pathways.
Positive regulation of cholesterol transport is tightly integrated with other metabolic pathways. PCK1 phosphorylation of INSIG1/2 links gluconeogenesis to lipogenesis, showing crosstalk between glucose and cholesterol metabolism. Sphingosine-1-phosphate signaling regulates ABCA1-mediated cholesterol efflux, providing a lipid-mediated feedback mechanism. TM4SF5-enriched mitochondria-lysosome contact sites mediate glucose-mediated mitochondrial reprogramming by cholesterol export, indicating that cholesterol transport can reciprocally influence mitochondrial function. These feedback loops ensure that cholesterol movement is matched to cellular demand and systemic lipid status.
Key Genes Involved in GO:0032376 positive regulation of cholesterol transport
The following genes and proteins are experimentally validated regulators or effectors of positive regulation of cholesterol transport, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ABCA1 | Mediates cholesterol efflux to apolipoproteins; regulated by S1P signaling | Target for atherosclerosis and reverse cholesterol transport studies |
| TREM2 | Promotes cholesterol uptake and foam cell formation | Key receptor in atherosclerosis and macrophage biology |
| DOCK7 | Enriched in extracellular vesicles; drives metastasis via RAC1/ABCA1 axis | Target for colorectal cancer metastasis research |
| PCK1 | Phosphorylates INSIG1/2 to promote lipogenesis | Links gluconeogenesis to cholesterol regulation |
| INSIG1 | Substrate of PCK1; regulates SREBP processing and lipogenesis | Node connecting glucose metabolism and lipid synthesis |
| INSIG2 | Substrate of PCK1; regulates SREBP processing and lipogenesis | Node connecting glucose metabolism and lipid synthesis |
| TM4SF5 | Facilitates cholesterol export at mitochondria-lysosome contact sites | Regulates mitochondrial reprogramming in cancer |
| RAC1 | Small GTPase downstream of DOCK7; involved in ABCA1 regulation | Mediator of metastasis and cholesterol transport |
| S1PR1 | Sphingosine-1-phosphate receptor; regulates ABCA1-mediated efflux | Target for macrophage cholesterol efflux |
| S1PR2 | Sphingosine-1-phosphate receptor; regulates ABCA1-mediated efflux | Target for macrophage cholesterol efflux |
| S1PR3 | Sphingosine-1-phosphate receptor; regulates ABCA1-mediated efflux | Target for macrophage cholesterol efflux |
| TRPV1 | Cholesterol-regulated ion channel | Model for cholesterol-protein interactions |
| TRPM8 | Cholesterol-regulated ion channel | Model for cholesterol-protein interactions |
| NMDA receptor | Cholesterol and neurosteroid-sensitive ion channel | Model for cholesterol modulation of synaptic function |
| APOE | Cholesterol transport lipoprotein | Relevant to atherosclerosis and neurodegeneration |
| SCARB1 | HDL receptor mediating cholesterol uptake | Relevant to reverse cholesterol transport |
| CYP46A1 | Cholesterol 24-hydroxylase; brain cholesterol turnover | Relevant to neurodegeneration |
| ABCA7 | Cholesterol transporter in microglia | Relevant to Alzheimer's disease |
How Is positive regulation of cholesterol transport Regulated?
Positive regulation of cholesterol transport is controlled by multiple signaling pathways. PCK1 phosphorylates INSIG1/2 to promote lipogenesis, directly linking gluconeogenic signaling to cholesterol regulation. Sphingosine-1-phosphate signaling regulates ABCA1-mediated cholesterol efflux in macrophages, providing a lipid-mediated control mechanism. Glucose availability drives mitochondrial reprogramming by cholesterol export at TM4SF5-enriched mitochondria-lysosome contact sites, showing metabolic regulation. TREM2 promotes cholesterol uptake and foam cell formation, indicating receptor-mediated regulation in atherosclerosis. Additionally, cholesterol itself regulates ion channels such as TRP channels and NMDA receptors, creating feedback loops that influence cellular excitability and neurosteroid signaling.
positive regulation of cholesterol transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TREM2 | Atherosclerosis; foam cell formation | Knockout and overexpression in macrophages |
| ABCA1 | Atherosclerosis; cholesterol efflux | Point mutation and knockout in macrophage cell lines |
| DOCK7 | Colorectal cancer metastasis | Knockout and knock-in in cancer cell lines |
| PCK1 | Metabolic syndrome; lipogenesis | Knockout and point mutation in hepatocytes |
| TM4SF5 | Cancer metabolism; mitochondrial reprogramming | Knockout and tagged knock-in in cancer cells |
Atherosclerosis and Cardiovascular Disease
Positive regulation of cholesterol transport is directly implicated in atherosclerosis. TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis, and its dysregulation accelerates plaque development. ABCA1-mediated cholesterol efflux, regulated by sphingosine-1-phosphate signaling, is a critical protective mechanism against foam cell formation. When positive regulation of cholesterol transport is impaired or misdirected, macrophages accumulate cholesterol, leading to atherosclerotic lesions.
Cancer and Metastasis
In colorectal cancer, tumor-associated macrophage-derived DOCK7-enriched extracellular vesicles drive tumor metastasis via the RAC1/ABCA1 axis, demonstrating that positive regulation of cholesterol transport can promote malignancy. TM4SF5-enriched mitochondria-lysosome contact sites mediate glucose-mediated mitochondrial reprogramming by cholesterol export, supporting cancer cell metabolic adaptation. PCK1 phosphorylation of INSIG1/2 links gluconeogenesis to lipogenesis, which can fuel tumor growth.
Metabolic and Immune Disorders
T cell cholesterol transport links intestinal immune responses to dietary lipid absorption, meaning that dysregulation can lead to immune dysfunction and metabolic imbalance. PCK1-mediated regulation of INSIG1/2 connects glucose metabolism to cholesterol synthesis, with implications for diabetes and metabolic syndrome. Sphingosine-1-phosphate signaling defects can impair cholesterol efflux, contributing to inflammatory diseases.
Neurological and Neurodegenerative Conditions
Cholesterol regulation of ion channels such as TRP channels and NMDA receptors affects neuronal excitability and synaptic function. Neurosteroid binding to NMDA receptors is modulated by cholesterol, linking lipid transport to neurotransmission. While direct evidence for GO:0032376 in neurodegeneration is limited, cholesterol transport pathways are broadly relevant to brain lipid homeostasis.
From positive regulation of cholesterol transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X causally regulate cholesterol efflux? | CRISPR knockout in macrophage cell lines |
| Does a specific phosphorylation site on INSIG1 control lipogenesis? | Point mutation knock-in in hepatocytes |
| How does DOCK7 enrichment in extracellular vesicles drive metastasis? | Knock-in of tagged DOCK7 in colorectal cancer cells |
| What is the effect of TREM2 overexpression on foam cell formation? | Overexpression in macrophages |
| How does TM4SF5 localization affect cholesterol export? | Tagged knock-in and live imaging in cancer cells |
| Which genes regulate T cell cholesterol transport? | CRISPR library screening in T cells |
How to Study the positive regulation of cholesterol transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cholesterol efflux assay | Movement of cholesterol from cells to acceptors | Assessing ABCA1 function |
| Cholesterol uptake assay | Internalization of cholesterol | Assessing TREM2 function |
| Oil Red O staining | Foam cell formation | Macrophage biology |
| Live-cell imaging | Localization and dynamics of transporters | TM4SF5 and DOCK7 studies |
| RNA-seq | Global gene expression changes | Pathway discovery |
| CRISPR library screening | Unbiased identification of regulators | T cell cholesterol transport |
| Proteomics | Protein abundance and modifications | PCK1-INSIG1/2 signaling |
| Structural biology | Cholesterol-protein interactions | TRP and NMDA receptor modulation |
CRISPR Knockout and Knock-in Models
CRISPR knockout is widely used to test the causal role of genes in positive regulation of cholesterol transport. For example, knockout of ABCA1 or TREM2 can be used to assess effects on cholesterol efflux and foam cell formation. Knock-in of point mutations, such as in INSIG1/2, allows dissection of phosphorylation-dependent regulation. Tagged knock-in of DOCK7 or TM4SF5 enables tracking of protein localization and vesicular transport.
Cholesterol Transport Assays
Cholesterol efflux and uptake assays are standard methods to measure positive regulation of cholesterol transport. These assays typically use radiolabeled or fluorescent cholesterol and measure movement to acceptors such as HDL or apolipoproteins. Foam cell formation can be quantified by Oil Red O staining in macrophages after TREM2 modulation. Mitochondria-lysosome contact site function can be assessed by live-cell imaging in TM4SF5 models.
Omics and Bioinformatics
RNA-seq and proteomics can identify global changes in gene expression and protein abundance upon modulation of cholesterol transport regulators. CRISPR library screening enables unbiased discovery of genes that positively regulate cholesterol transport. Bioinformatics integration of transcriptomic and lipidomic data can reveal pathways connected to GO:0032376.
Imaging and Structural Approaches
Live-cell imaging of tagged transporters and contact sites provides spatial and temporal resolution of cholesterol movement. Structural studies of ion channels such as TRP channels and NMDA receptors reveal how cholesterol and neurosteroids modulate their function. These methods complement genetic approaches to build a mechanistic understanding of positive regulation of cholesterol transport.
How CRISPR Can Be Used to Study GO:0032376 positive regulation of cholesterol transport
Knockout
CRISPR knockout is used to eliminate genes such as ABCA1, TREM2, or DOCK7 to determine whether they are required for positive regulation of cholesterol transport. For example, ABCA1 knockout reduces cholesterol efflux, confirming its essential role. TREM2 knockout impairs cholesterol uptake and foam cell formation. DOCK7 knockout in cancer cells can reduce extracellular vesicle-mediated metastasis.
Point Mutation
Point mutation knock-in allows precise testing of phosphorylation sites or catalytic residues. For instance, mutation of PCK1 phosphorylation sites on INSIG1/2 can reveal their role in lipogenesis. Point mutations in ABCA1 can dissect its transport cycle. This approach is ideal for separating specific molecular events from broader protein functions.
Knock-in
Knock-in of tagged versions of DOCK7, TM4SF5, or ABCA1 enables visualization and biochemical isolation of transport complexes. Tagged knock-in can also be used to monitor protein trafficking and contact site dynamics in live cells. This is particularly useful for studying vesicular transport and organelle contact sites.
Overexpression
Overexpression of TREM2, ABCA1, or TM4SF5 can enhance cholesterol transport and reveal gain-of-function phenotypes. For example, TREM2 overexpression increases cholesterol uptake and foam cell formation. Overexpression of TM4SF5 promotes cholesterol export and mitochondrial reprogramming. This approach is valuable for testing sufficiency in transport regulation.
How EDITGENE Supports positive regulation of cholesterol transport Research
Researchers studying positive regulation of cholesterol transport-related genes often need to determine whether a candidate gene is causally involved in cholesterol movement, and CRISPR-based models provide the most direct way to establish causality. EDITGENE offers a comprehensive suite of services to support these investigations, from knockout and point mutation to knock-in, overexpression, library screening, and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cholesterol transport research.
Frequently Asked Questions About positive regulation of cholesterol transport
What is GO:0032376 positive regulation of cholesterol transport?
GO:0032376 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate, or extent of the directed movement of cholesterol into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore.
What genes are involved in positive regulation of cholesterol transport?
Key genes include ABCA1, TREM2, DOCK7, PCK1, INSIG1, INSIG2, TM4SF5, RAC1, and sphingosine-1-phosphate receptors.
How does TREM2 regulate cholesterol transport?
TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis, acting as a receptor that increases cholesterol internalization.
What is the role of ABCA1 in cholesterol efflux?
ABCA1 mediates cholesterol efflux to apolipoproteins, and its activity is regulated by sphingosine-1-phosphate signaling in macrophages.
How is positive regulation of cholesterol transport linked to cancer?
DOCK7-enriched extracellular vesicles from tumor-associated macrophages drive tumor metastasis via the RAC1/ABCA1 axis, and TM4SF5-mediated cholesterol export supports cancer cell metabolic reprogramming.
What experimental models are used to study GO:0032376?
CRISPR knockout, point mutation knock-in, tagged knock-in, overexpression cell models, and CRISPR library screening are commonly used.
How does PCK1 regulate cholesterol transport?
PCK1 phosphorylates INSIG1/2 to promote lipogenesis, linking gluconeogenesis to cholesterol regulation.
What is the connection between cholesterol transport and the immune system?
T cell cholesterol transport links intestinal immune responses to dietary lipid absorption, integrating systemic metabolism with immunity.
Can cholesterol transport be studied with live-cell imaging?
Yes, tagged knock-in of proteins like TM4SF5 and DOCK7 enables live-cell imaging of cholesterol transport dynamics and organelle contact sites.
What services does EDITGENE offer for cholesterol transport research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for cholesterol transport research.
Conclusion
GO:0032376 positive regulation of cholesterol transport is a central biological process that controls cholesterol movement into, out of, and within cells. Its dysregulation is linked to atherosclerosis, cancer, and metabolic disorders, making it a high-priority research area. Mechanistic studies using CRISPR knockout, point mutation, knock-in, and overexpression models have identified key regulators such as ABCA1, TREM2, DOCK7, PCK1, and TM4SF5. Continued investigation of this process will likely yield new therapeutic targets for cardiovascular and metabolic diseases.
References
- 1. Gao Y et al.. 2025. T cell cholesterol transport links intestinal immune responses to dietary lipid absorption.. Science 390(6769):eadt4169 PMID: 41066556
- 2. Xu D et al.. 2020. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.. Nature 580(7804):530-535 PMID: 32322062
- 3. Kim JE et al.. 2024. Glucose-mediated mitochondrial reprogramming by cholesterol export at TM4SF5-enriched mitochondria-lysosome contact sites.. Cancer Commun (Lond) 44(1):47-75 PMID: 38133457
- 4. Guo X et al.. 2023. TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis.. Cell Mol Life Sci 80(5):137 PMID: 37133566
- 5. Kang H et al.. 2025. Mechanism of conductance control and neurosteroid binding in NMDA receptors.. Nature 648(8092):220-228 PMID: 41162707
- 6. Chen W et al.. 2024. Tumour-associated macrophage-derived DOCK7-enriched extracellular vesicles drive tumour metastasis in colorectal cancer via the RAC1/ABCA1 axis.. Clin Transl Med 14(2):e1591 PMID: 38385857
- 7. Morales-Lázaro SL et al.. 2017. Multiple Mechanisms of Regulation of Transient Receptor Potential Ion Channels by Cholesterol.. Curr Top Membr 80:139-161 PMID: 28863814
- 8. Vaidya M et al.. 2019. Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages.. J Lipid Res 60(3):506-515 PMID: 30655318
